Viewing Study NCT01313494


Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2025-12-27 @ 11:02 PM
Study NCT ID: NCT01313494
Status: COMPLETED
Last Update Posted: 2017-02-01
First Post: 2011-03-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Chronic Obstructive Pulmonary Disease (COPD) Trial Investigating Roflumilast on Safety and Effectiveness in China, Hong Kong and Singapore:
Sponsor: AstraZeneca
Organization: